Cohesys awarded $1.62M from MTEC to support BoneTape, a revolutionary fracture fixation technology

Ontario Industry UpdatesOBIO News
Written By Arsheen Kaur

Cohesys, an innovative medical device company focused on novel solutions for fracture treatment, has been selected for a $1.62M award by the Medical Technology Enterprise Consortium (MTEC) in collaboration with the Department of Defense (DoD) U.S. Army Medical Research and Development Command (USAMRDC). This award will advance development and clinical validation for BoneTape, a revolutionary resorbable bone fixation device designed to improve fracture treatment.

Cohesys is an OBIO® member and an alumnus of our BDSP™, CAAP® and H2BB™ programs.

Arsheen Kaur
Previous

Eurofins CDMO Alphora announces the completion of a new pilot scale biologics development facility
Next

AI-Driven Clinical Trial Pre-Screening by K2 Medical Research, Magruder Eye Institute and RetiSpec